Health and Healthcare
5865 Articles
ThinkstockShares of Keryx Biopharmaceuticals Inc. (NASDAQ: KERX) sank on Monday after the company announced that there will be an interruption in…
Finally, concerns about biotech seem to be waning. An RBC research report notes that at the recent political conventions there…
Shares of Biogen and, especially, Ionis Pharmaceuticals made handy gains early Monday morning following favorable interim results from a late-stage…
Gilead Sciences reported its earnings on Monday of last week, and since that time there has been much analyst activity…
When Boston Scientific reported second-quarter results Wednesday, revenues were up 10% overall, with medical and surgical product sales up nearly…
These three biotech companies not only have data that could prove to be huge, but they have been absolutely hammered…
The recent performance from Gilead Sciences has analysts and investors concerned about the future. Argus believes that the headwinds are blowing…
Shares of Seres Therapeutics took an absolute dive early in Friday’s session as the company stared down the barrel of…
AbbVie released a better-than-expected second-quarter earnings report before the markets opened on Friday.
Merck reported better-than-expected second-quarter 2016 results before markets opened Friday morning.
Bristol-Myers Squibb released a better-than-expected second-quarter earnings report before the markets opened on Thursday.
Overall, investors were content after Celgene reported its second-quarter financial results, with wins on both the top and bottom lines.
Amgen is expected to report its second-quarter financial results after the markets close on Wednesday. Will it go the same…
The short interest data have been released for the July 15 settlement date. For the selected pharmaceutical stocks, short interest…
A new JPMorgan research report says it time to buy the health care sector and sell consumer staples, which have…
Our top personal finance-related articles today. Your wallet will thank you later.